search button

Retroviruses prepared from human DAF expressing murine packaging cells acquire resistance against human serum.

  • Authors:
    • A Hiasa
    • M Watanabe
    • H Okada
    • K Ikenaka
    • T Fujita
    • T Yoshimatsu
    • T Kanematsu
    • H Shiku

  • View Affiliations

  • Published online on: June 1, 1999     https://doi.org/10.3892/ijo.14.6.1091
  • Pages: 1091-1097
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The complement system of the human body inactivates the infectious ability of retroviruses injected as an artificial gene transfer vector. We established new murine leukemia virus (MuLV) packaging cell lines; D2SS and D7S which express decay-accelerating factor (DAF) on their surface. Both D2SS and D7S were resistant against incubation with fresh human serum. Moreover, the retroviruses produced from these packaging cell lines were also resistant to serum treatment. This resistance can be inhibited by DAF neutralizing antibody 1C6. These data demostrate that DAF induces a partial protection of MuLV infection from the human complement system.

Related Articles

Journal Cover

Jun 1999
Volume 14 Issue 6

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 5.2
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 11.4
  • CiteScore Rank: Q1: #40/366 Oncology
  • Source Normalized Impact per Paper (SNIP): 1.125
  • SCImago Journal Rank (SJR): 1.105
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Hiasa A, Watanabe M, Okada H, Ikenaka K, Fujita T, Yoshimatsu T, Kanematsu T and Shiku H: Retroviruses prepared from human DAF expressing murine packaging cells acquire resistance against human serum.. Int J Oncol 14: 1091-1097, 1999
APA
Hiasa, A., Watanabe, M., Okada, H., Ikenaka, K., Fujita, T., Yoshimatsu, T. ... Shiku, H. (1999). Retroviruses prepared from human DAF expressing murine packaging cells acquire resistance against human serum.. International Journal of Oncology, 14, 1091-1097. https://doi.org/10.3892/ijo.14.6.1091
MLA
Hiasa, A., Watanabe, M., Okada, H., Ikenaka, K., Fujita, T., Yoshimatsu, T., Kanematsu, T., Shiku, H."Retroviruses prepared from human DAF expressing murine packaging cells acquire resistance against human serum.". International Journal of Oncology 14.6 (1999): 1091-1097.
Chicago
Hiasa, A., Watanabe, M., Okada, H., Ikenaka, K., Fujita, T., Yoshimatsu, T., Kanematsu, T., Shiku, H."Retroviruses prepared from human DAF expressing murine packaging cells acquire resistance against human serum.". International Journal of Oncology 14, no. 6 (1999): 1091-1097. https://doi.org/10.3892/ijo.14.6.1091